Nuvation Bio Inc (NUVB) Annual Income Statement (USD)
NUVB Quarterly Financials (USD)
Frequently Asked Questions About Nuvation Bio Inc (NUVB) Stock
Nuvation Bio Inc's (NUVB) last reported annual revenue was USD 0.00.
Nuvation Bio Inc's (NUVB) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Nuvation Bio Inc's(NUVB) is not profitable as of its last reported annual financials.
The net profit margin for Nuvation Bio Inc's(NUVB) from its laster reported year is N/A
The return on equity (ROE) for Nuvation Bio Inc's(NUVB) from its last reported annual financials is : -95.54%
The return on assets (ROA) for Nuvation Bio Inc's(NUVB) from its last reported annual financials is : -13.98%
The return on invested capital (ROIC) for Nuvation Bio Inc's(NUVB) from its last reported annual financials is : -15.84%
The Debt to Equity ratio for Nuvation Bio Inc's(NUVB) from its last reported annual financials is : 0.00%
The dividend yield for Nuvation Bio Inc's(NUVB) from its laster reported year is 0.00%
Nuvation Bio Inc's(NUVB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NUVB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
